X4 Pharmaceuticals, Inc. Common Stock XFOR

$3.50 -13.24% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-09-09 View →
8-K 8-K 2026-09-08 View →
4 FORM 4 2026-08-13 View →
4 FORM 4 2026-08-13 View →
10-Q 10-Q 2026-08-06 View →
4 FORM 4 2026-07-01 View →
4 FORM 4 2026-07-01 View →
8-K 8-K 2026-07-01 View →
4 FORM 4 2026-05-13 View →
8-K 8-K 2026-05-12 View →
S-3 S-3 2026-05-06 View →
10-Q 10-Q 2026-05-06 View →
DEF 14A DEF 14A 2026-03-20 View →
10-K 10-K 2026-03-17 View →
4 FORM 4 2026-01-07 View →
4 FORM 4 2026-01-05 View →
4 FORM 4 2026-01-05 View →
4 FORM 4 2026-01-05 View →
10-Q 10-Q 2025-11-05 View →
8-K 8-K 2025-11-05 View →
4 FORM 4 2025-10-31 View →
4 FORM 4 2025-10-31 View →
4 FORM 4 2025-10-31 View →
4 FORM 4 2025-10-27 View →
8-K 8-K 2025-10-27 View →
424B5 424B5 2025-10-24 View →
424B5 424B5 2025-10-23 View →
8-K 8-K 2025-09-17 View →
S-3 S-3 2025-09-10 View →
8-K 8-K 2025-08-25 View →
4 FORM 4 2025-08-14 View →
4 FORM 4 2025-08-14 View →
4 FORM 4 2025-08-14 View →
8-K 8-K 2025-08-13 View →
8-K 8-K 2025-08-12 View →
10-Q 10-Q 2025-08-08 View →
4 FORM 4 2025-07-03 View →
8-K 8-K 2025-06-23 View →
424B5 424B5 2025-06-23 View →
8-K 8-K 2025-06-11 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$3.50
Market Cap
$347.51 million
52-Week Range
$1.35 – $4.83
Average Volume
683K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.